Cargando…

Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5

SIMPLE SUMMARY: About 10–20 percent of patients with breast cancer are diagnosed with triple-negative breast cancer (TNBC). These tumors are named for their lack of expression of estrogen receptor (ER), progesterone receptor (PR), and amplification of human epidermal growth factor receptor 2 (HER2)....

Descripción completa

Detalles Bibliográficos
Autores principales: Rabe, Daniel C., Walker, Nykia D., Rustandy, Felicia D., Wallace, Jessica, Lee, Jiyoung, Stott, Shannon L., Rosner, Marsha Rich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303898/
https://www.ncbi.nlm.nih.gov/pubmed/34298673
http://dx.doi.org/10.3390/cancers13143459
_version_ 1783727200574373888
author Rabe, Daniel C.
Walker, Nykia D.
Rustandy, Felicia D.
Wallace, Jessica
Lee, Jiyoung
Stott, Shannon L.
Rosner, Marsha Rich
author_facet Rabe, Daniel C.
Walker, Nykia D.
Rustandy, Felicia D.
Wallace, Jessica
Lee, Jiyoung
Stott, Shannon L.
Rosner, Marsha Rich
author_sort Rabe, Daniel C.
collection PubMed
description SIMPLE SUMMARY: About 10–20 percent of patients with breast cancer are diagnosed with triple-negative breast cancer (TNBC). These tumors are named for their lack of expression of estrogen receptor (ER), progesterone receptor (PR), and amplification of human epidermal growth factor receptor 2 (HER2). These genes are targeted by therapies in other breast cancer patients. However, most TNBC patients recur within 5 years. Understanding how and why these tumors metastasize will help clinicians better treat these underserved cancer patients. TNBC tumors are highly infiltrated by tumor-associated macrophages (TAMs) that promote tumorigenesis and metastasis. Our study elucidates how the tumor co-opts macrophages recruited to the tumor through extracellular vesicles (EVs), further increasing tumor metastasis. Expression of tumor CCL5 regulates EV secretion and cargo that further alters macrophage phenotype to drive tumor metastasis. Together, our data suggest a more extensive role of EVs in the biology of tumor metastasis as well as their potential use as biomarkers. ABSTRACT: Purpose: To understand how tumor cells alter macrophage biology once they are recruited to triple-negative breast cancer (TNBC) tumors by CCL5. Method: Mouse bone marrow derived macrophage (BMDMs) were isolated and treated with recombinant CCL5 protein alone, with tumor cell conditioned media, or with tumor extracellular vesicles (EVs). Media from these tumor EV-educated macrophages (TEMs) was then used to determine how these macrophages affect TNBC invasion. To understand the mechanism, we assayed the cytokine secretion from these macrophages to determine how they impact tumor cell invasion. Tumor CCL5 expression was varied in tumors to determine its role in regulating macrophage biology through EVs. Results: Tumor EVs are a necessary component for programming naïve macrophages toward a pro-metastatic phenotype. CCL5 expression in the tumor cells regulates both EV biogenesis/secretion/cargo and macrophage EV-education toward a pro-metastatic phenotype. Analysis of the tumor EV-educated macrophages (TEMs) showed secretion of a variety of factors including CXCL1, CTLA-4, IFNG, OPN, HGF, TGFB, and CCL19 capable of remodeling the surrounding tumor stroma and immune infiltrate. Injection of tumor cells with macrophages educated by metastatic tumor cell EVs into mice increased tumor metastasis to the lung. Conclusion: These results demonstrate that tumor-derived EVs are key mediators of macrophage education and likely play a more complex role in modulating tumor therapeutic response by regulating the tumor immune infiltrate.
format Online
Article
Text
id pubmed-8303898
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83038982021-07-25 Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5 Rabe, Daniel C. Walker, Nykia D. Rustandy, Felicia D. Wallace, Jessica Lee, Jiyoung Stott, Shannon L. Rosner, Marsha Rich Cancers (Basel) Article SIMPLE SUMMARY: About 10–20 percent of patients with breast cancer are diagnosed with triple-negative breast cancer (TNBC). These tumors are named for their lack of expression of estrogen receptor (ER), progesterone receptor (PR), and amplification of human epidermal growth factor receptor 2 (HER2). These genes are targeted by therapies in other breast cancer patients. However, most TNBC patients recur within 5 years. Understanding how and why these tumors metastasize will help clinicians better treat these underserved cancer patients. TNBC tumors are highly infiltrated by tumor-associated macrophages (TAMs) that promote tumorigenesis and metastasis. Our study elucidates how the tumor co-opts macrophages recruited to the tumor through extracellular vesicles (EVs), further increasing tumor metastasis. Expression of tumor CCL5 regulates EV secretion and cargo that further alters macrophage phenotype to drive tumor metastasis. Together, our data suggest a more extensive role of EVs in the biology of tumor metastasis as well as their potential use as biomarkers. ABSTRACT: Purpose: To understand how tumor cells alter macrophage biology once they are recruited to triple-negative breast cancer (TNBC) tumors by CCL5. Method: Mouse bone marrow derived macrophage (BMDMs) were isolated and treated with recombinant CCL5 protein alone, with tumor cell conditioned media, or with tumor extracellular vesicles (EVs). Media from these tumor EV-educated macrophages (TEMs) was then used to determine how these macrophages affect TNBC invasion. To understand the mechanism, we assayed the cytokine secretion from these macrophages to determine how they impact tumor cell invasion. Tumor CCL5 expression was varied in tumors to determine its role in regulating macrophage biology through EVs. Results: Tumor EVs are a necessary component for programming naïve macrophages toward a pro-metastatic phenotype. CCL5 expression in the tumor cells regulates both EV biogenesis/secretion/cargo and macrophage EV-education toward a pro-metastatic phenotype. Analysis of the tumor EV-educated macrophages (TEMs) showed secretion of a variety of factors including CXCL1, CTLA-4, IFNG, OPN, HGF, TGFB, and CCL19 capable of remodeling the surrounding tumor stroma and immune infiltrate. Injection of tumor cells with macrophages educated by metastatic tumor cell EVs into mice increased tumor metastasis to the lung. Conclusion: These results demonstrate that tumor-derived EVs are key mediators of macrophage education and likely play a more complex role in modulating tumor therapeutic response by regulating the tumor immune infiltrate. MDPI 2021-07-10 /pmc/articles/PMC8303898/ /pubmed/34298673 http://dx.doi.org/10.3390/cancers13143459 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rabe, Daniel C.
Walker, Nykia D.
Rustandy, Felicia D.
Wallace, Jessica
Lee, Jiyoung
Stott, Shannon L.
Rosner, Marsha Rich
Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title_full Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title_fullStr Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title_full_unstemmed Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title_short Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
title_sort tumor extracellular vesicles regulate macrophage-driven metastasis through ccl5
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303898/
https://www.ncbi.nlm.nih.gov/pubmed/34298673
http://dx.doi.org/10.3390/cancers13143459
work_keys_str_mv AT rabedanielc tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT walkernykiad tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT rustandyfeliciad tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT wallacejessica tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT leejiyoung tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT stottshannonl tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5
AT rosnermarsharich tumorextracellularvesiclesregulatemacrophagedrivenmetastasisthroughccl5